Industry & Services >> CEO Interviews >> February 19, 2001
DR. ALEXANDER K. ARROW is the Chief Financial Officer of The Patent &
License Exchange, Inc. (pl-x), Dr. Arrow's team performs an operational
role: it supplies a market driven calculated value for every unit of
intellectual property listed on the Exchange, forming one of pl-x's main
revenue lines. Prior to joining pl-x Dr. Arrow was Vice President,
Research at Wedbush Morgan Securities and led the firm's medical
technology sell-side research team. He is a frequent speaker at various
investors' conferences. Dr. Arrow's background includes securities
analysis, technology analysis, and life science research. Prior to
Wedbush Morgan, he was a General Surgery Resident at the UCLA Medical
Center, a Management Consultant at Arthur D. Little, Inc., a
Biotechnology Analyst for Hambro Biofinance, Inc., and a biomaterials
researcher at MIT. He is one of the foremost authorities on the wound
care market and has participated in three initial public offerings. Dr.
Arrow is a Chartered Financial Analyst, holds an MD from Harvard
University, and a BA in Physics from Cornell University. He is on the
Board of Directors of the Southern California Biomedical Council, and a
member of the Association for Investment Management and Research. Profile
Dr. Arrow: The Patent & License Exchange (pl-x) is a two-year-old
company which transforms intellectual property assets into
